Imran Alibhai is the founder of Tvardi Therapeutics. Tvardi Therapeutics has raised $74M in total funding. Latest round: Series B. Based in Houston, USA.
Imran Alibhai is the Chief Executive Officer of Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company. Tvardi Therapeutics, founded in 2017, focuses on developing small molecule inhibitors of STAT3 for cancer, chronic inflammation, and fibrosis. The company raised a $74 million Series B financing round in June 2021 to advance its clinical programs.
Full founder directory · Investor directory · Company funding database · Fundraising library